MOVE Medacta Group SA
Medacta Group SA develops, manufactures, and distributes orthopedic and neurosurgical medical devices Latin America, North America, the Asia-Pacific, and Middle East and Africa. It offers personalized 3D planning tools for use in hip, knee, shoulder, joint replacement, sports medicine, and spine surgery. The company was founded in 1958 and is headquartered in Castel San Pietro, Switzerland.…
Industry Peers
Medical DevicesKey Statistics
About Medacta Group (SWX: MOVE)
›
Medacta Group (SWX: MOVE) is listed on the SIX Swiss Exchange, where its shares trade in CHF. It belongs to the Medical Devices industry, part of the Healthcare sector, and reports about 2,273 employees.
The shares were at 103.00 CHF on 19 November 2026, down 30.8% over 52 weeks. Its 52-week range is 102.40 CHF to 177.20 CHF, and it trades at the bottom of that range.
At a market capitalisation of 2.05B CHF, it trades at 28.8 times trailing earnings and 20.2 times forward earnings. The median trailing P/E of its 19 largest Medical Devices peers is 25.6, a premium of 12% for MOVE. It pays a dividend yielding 1.05% (it pays out 31% of its earnings), against a median of 2.36% among the dividend payers in that peer group.
Medacta Group reports return on equity of 20.9%, an operating margin of 15.2% and revenue up 7.0% year over year.
Its debt exceeds its cash by 284.59M EUR, a debt-to-equity ratio of 0.57. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 6 analysts cover the stock, with an average rating of Buy; their mean price target of 149.86 CHF is 45.5% above the current price. The next earnings report is expected on 10 March 2027.